Tandem Diabetes Care, Inc. (TNDM)

NASDAQ

$22.12

+$0.73 (3.41%)

Today

No price data available for this timeframe.

Key Statistics

Day Range

$21.34$22.16

Open $21.58

52 Week Range

$9.98$38.28

Previous Close $21.39

Market Cap1.50B

Volume1.45M

Avg Volume2.12M

P/E (TTM)-7.36

EPS (TTM)$-3.01

Dividend / YieldN/A

Dividend StreakN/A

Latest News for Tandem Diabetes Care, Inc.

DEC14

ROSEN, A GLOBAL AND LEADING LAW FIRM, Encourages Tandem Diabetes Care, Inc. Investors to Inquire About Securities Class Action Investigation - TNDM

New York, New York--(Newsfile Corp. - December 14, 2025) - WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Tan...

newsfilecorp.com•2 days ago

DEC13

TNDM Investor News: If You Have Suffered Losses in Tandem Diabetes Care, Inc. (NASDAQ: TNDM), You Are Encouraged to Contact The Rosen Law Firm About Your Rights

NEW YORK, Dec. 13, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Tandem Diabetes Ca...

globenewswire.com•2 days ago

DEC12

Don't Buy Tandem Diabetes Care Until This Big Thing Happens

Tandem Diabetes Care's top-line growth hasn't been great over the past few years. If it can successfully address challenges detrimental to revenue growth, it may become an attractive stock -- even wit...

fool.com•4 days ago

DEC11

Rosen Law Firm Encourages Tandem Diabetes Care, Inc. Investors to Inquire About Securities Class Action Investigation - TNDM

NEW YORK , Dec. 11, 2025 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Tandem Diabetes Care,...

prnewswire.com•4 days ago

DEC10

ROSEN, A TOP-RANKED LAW FIRM, Encourages Tandem Diabetes Care, Inc. Investors to Inquire About Securities Class Action Investigation - TNDM

New York, New York--(Newsfile Corp. - December 10, 2025) - WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Tan...

newsfilecorp.com•5 days ago

DEC10

TNDM Investor News: If You Have Suffered Losses in Tandem Diabetes Care, Inc. (NASDAQ: TNDM), You Are Encouraged to Contact The Rosen Law Firm About Your Rights

NEW YORK, Dec. 10, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Tandem Diabetes Ca...

globenewswire.com•5 days ago

DEC9

Reasons to Hold Tandem Diabetes Stock in Your Portfolio for Now

TNDM's global expansion and strategic integrations fuel growth potential, even as pump reliance and macro pressures weigh on performance....

zacks.com•7 days ago

DEC8

ROSEN, LEADING INVESTOR COUNSEL, Encourages Tandem Diabetes Care, Inc. Investors to Inquire About Securities Class Action Investigation - TNDM

New York, New York--(Newsfile Corp. - December 8, 2025) - WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Tand...

newsfilecorp.com•7 days ago

DEC7

ROSEN, A HIGHLY RECOGNIZED LAW FIRM, Encourages Tandem Diabetes Care, Inc. Investors to Inquire About Securities Class Action Investigation - TNDM

New York, New York--(Newsfile Corp. - December 7, 2025) - WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Tand...

newsfilecorp.com•8 days ago

DEC6

TNDM Investor News: If You Have Suffered Losses in Tandem Diabetes Care, Inc. (NASDAQ: TNDM), You Are Encouraged to Contact The Rosen Law Firm About Your Rights

NEW YORK, Dec. 06, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Tandem Diabetes Ca...

globenewswire.com•10 days ago